77 related articles for article (PubMed ID: 2125379)
21. Differential energy requirements for platelet responses. A simultaneous study of aggregation, three secretory processes, arachidonate liberation, phosphatidylinositol breakdown and phosphatidate production.
Holmsen H; Kaplan KL; Dangelmaier CA
Biochem J; 1982 Oct; 208(1):9-18. PubMed ID: 6218802
[TBL] [Abstract][Full Text] [Related]
22. The initial action of thrombin on platelets. Conversion of phosphatidylinositol to phosphatidic acid preceding the production of arachidonic acid.
Lapetina EG; Billah MM; Cuatrecasas P
J Biol Chem; 1981 May; 256(10):5037-40. PubMed ID: 6785276
[TBL] [Abstract][Full Text] [Related]
23. Psychotropic drugs interfere with the tight coupling of polyphosphoinositide cycle metabolites in human platelets: a result of receptor-independent drug intercalation in the plasma membrane?
Oruch R; Hodneland E; Pryme IF; Holmsen H
Biochim Biophys Acta; 2008 Oct; 1778(10):2165-76. PubMed ID: 18503745
[TBL] [Abstract][Full Text] [Related]
24. Diacylglycerol lipase pathway is a minor source of released arachidonic acid in thrombin-stimulated human platelets.
Mahadevappa VG; Holub BJ
Biochem Biophys Res Commun; 1986 Feb; 134(3):1327-33. PubMed ID: 3081001
[TBL] [Abstract][Full Text] [Related]
25. Tight coupling of thrombin-induced acid hydrolase secretion and phosphatidate synthesis to receptor occupancy in human platelets.
Holmsen H; Dangelmaier CA; Rongved S
Biochem J; 1984 Aug; 222(1):157-67. PubMed ID: 6089753
[TBL] [Abstract][Full Text] [Related]
26. Effect of membrane cholesterol on phospholipid metabolism in thrombin-stimulated platelets. Enhanced activation of platelet phospholipase(s) for liberation of arachidonic acid.
Kramer RM; Jakubowski JA; Vaillancourt R; Deykin D
J Biol Chem; 1982 Jun; 257(12):6844-9. PubMed ID: 7085608
[TBL] [Abstract][Full Text] [Related]
27. Tight binding inhibitors of 85-kDa phospholipase A2 but not 14-kDa phospholipase A2 inhibit release of free arachidonate in thrombin-stimulated human platelets.
Bartoli F; Lin HK; Ghomashchi F; Gelb MH; Jain MK; Apitz-Castro R
J Biol Chem; 1994 Jun; 269(22):15625-30. PubMed ID: 8195211
[TBL] [Abstract][Full Text] [Related]
28. Inositol lipids, phosphatidate and diacylglycerol share stearoylarachidonoylglycerol as a common backbone in thrombin-stimulated human platelets.
Mauco G; Dangelmaier CA; Smith JB
Biochem J; 1984 Dec; 224(3):933-40. PubMed ID: 6525180
[TBL] [Abstract][Full Text] [Related]
29. Thrombin-induced platelet responses differ in requirement for receptor occupancy. Evidence for tight coupling of occupancy and compartmentalized phosphatidic acid formation.
Holmsen H; Dangelmaier CA; Holmsen HK
J Biol Chem; 1981 Sep; 256(18):9393-6. PubMed ID: 6270083
[No Abstract] [Full Text] [Related]
30. Stimulated platelets release equivalent amounts of arachidonate from phosphatidylcholine, phosphatidylethanolamine, and inositides.
Broekman MJ
J Lipid Res; 1986 Aug; 27(8):884-91. PubMed ID: 3021886
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of calmodulin antagonists on phospholipases A2 and C in thrombin-stimulated platelets.
Walenga RW; Opas EE; Feinstein MB
J Biol Chem; 1981 Dec; 256(23):12523-8. PubMed ID: 6795206
[No Abstract] [Full Text] [Related]
32. The stimulatory effects of cationic amphiphilic drugs on human platelets treated with thrombin.
Tharmapathy P; Fukami MH; Holmsen H
Biochem Pharmacol; 2000 Nov; 60(9):1267-77. PubMed ID: 11008120
[TBL] [Abstract][Full Text] [Related]
33. The phosphatidylinositol cycle and the regulation of arachidonic acid production.
Lapetina EG; Billah MM; Cuatrecasas P
Nature; 1981 Jul; 292(5821):367-9. PubMed ID: 6265791
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of human platelets with low concentrations of thrombin: evidence for equimolar accumulation of inositol trisphosphates and phosphatidic acid.
Tysnes OB; Steen VM; Aarbakke GM; Holmsen H
Int J Biochem; 1991; 23(3):305-10. PubMed ID: 2044838
[TBL] [Abstract][Full Text] [Related]
35. Shape change induced in human platelets by platelet-activating factor. Correlation with the formation of phosphatidic acid and phosphorylation of a 40,000-dalton protein.
Lapetina EG; Siegel FL
J Biol Chem; 1983 Jun; 258(12):7241-4. PubMed ID: 6345519
[TBL] [Abstract][Full Text] [Related]
36. Influence of the antianginal drug trapidil and its derivative AR 12463 on arachidonic acid liberation and thromboxane formation in thrombin-stimulated platelets.
Block HU; Dunemann A; Niebisch M; Mest HJ
Biomed Biochim Acta; 1988; 47(10-11):S141-4. PubMed ID: 3248101
[TBL] [Abstract][Full Text] [Related]
37. Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. Epinephrine does not induce phospholipase C activation or platelet shape change.
Siess W; Weber PC; Lapetina EG
J Biol Chem; 1984 Jul; 259(13):8286-92. PubMed ID: 6429141
[TBL] [Abstract][Full Text] [Related]
38. Incorporation of 3H-arachidonic acid into platelet phospholipids of patients with schizophrenia.
Yao JK; van Kammen DP
Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):21-6. PubMed ID: 8888119
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of ceruloplasmin against lipid peroxidation in blood platelets.
Wachowicz B; Krajewski T; Zbikowska H
Acta Biochim Pol; 1990; 37(2):261-6. PubMed ID: 2072984
[TBL] [Abstract][Full Text] [Related]
40. Effect of cisplatin on lipid peroxidation in blood platelets.
Wachowicz B
Acta Biochim Pol; 1991; 38(1):87-90. PubMed ID: 1796713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
